Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Emanuele Rando, Francesca Giovannenze, Rita Murri & Emilio Sacco. (2022) A review of recent advances in the treatment of adults with complicated urinary tract infection. Expert Review of Clinical Pharmacology 15:9, pages 1053-1066.
Read now
Read now
Daniele Roberto Giacobbe, Jason A. Roberts, Mohd H. Abdul-Aziz, Etienne de Montmollin, Jean-François Timsit & Matteo Bassetti. (2022) Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective. Expert Review of Anti-infective Therapy 20:7, pages 963-979.
Read now
Read now
Katerina G. Tsegka, Georgios L. Voulgaris, Margarita Kyriakidou, Anastasios Kapaskelis & Matthew E. Falagas. (2022) Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review. Expert Review of Anti-infective Therapy 20:1, pages 33-43.
Read now
Read now
Katerina G Tsegka, Georgios L Voulgaris, Margarita Kyriakidou & Matthew E Falagas. (2020) Intravenous fosfomycin for the treatment of patients with central nervous system infections: evaluation of the published evidence. Expert Review of Anti-infective Therapy 18:7, pages 657-668.
Read now
Read now
George Dimopoulos, Despoina Koulenti, Suzanne L. Parker, Jason A. Roberts, Kostoula Arvaniti & Garyphalia Poulakou. (2019) Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?. Expert Review of Anti-infective Therapy 17:3, pages 201-210.
Read now
Read now
Michael E. Plazak, Pranita D. Tamma & Emily L. Heil. (2018) The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria. Expert Opinion on Pharmacotherapy 19:18, pages 2019-2031.
Read now
Read now
Andrew F. Shorr, Jason M. Pogue & John F. Mohr. (2017) Intravenous fosfomycin for the treatment of hospitalized patients with serious infections. Expert Review of Anti-infective Therapy 15:10, pages 935-945.
Read now
Read now
Ilias Karaiskos & Helen Giamarellou. (2014) Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opinion on Pharmacotherapy 15:10, pages 1351-1370.
Read now
Read now
Alexandre P Zavascki, Jurgen B Bulitta & Cornelia B Landersdorfer. (2013) Combination therapy for carbapenem-resistant Gram-negative bacteria. Expert Review of Anti-infective Therapy 11:12, pages 1333-1353.
Read now
Read now
Articles from other publishers (51)
Anirban Roy Chowdhury, Sujal Shah, Rahul Y. Kapse, Tushar Mehta & Amit Mukharya. (2024) ICP-MS: a tool for detection and quantitation of fosfomycin residues in cleaning samples of finished product by estimation of phosphorous load. Journal of Analytical Atomic Spectrometry.
Crossref
Crossref
Alassane Halawen Mohamed, René Dembélé, Alio Mahamadou Fody, Alix Bénédicte Kagambèga, Hiliassa Coulibaly, Frédéric François Bado, Chaibou Salaou, Laouali Boubou, Alkassoum Ibrahim, Eric Adehossi Omar & Nicolas Barro. (2023) Efficacy of Fosfomycin against Extended Spectrum Beta-Lactamase-Producing Escherichia coli Isolated from Patient Urinary Cultures in the General Reference Hospital of Niamey, Niger. Uro 3:4, pages 262-270.
Crossref
Crossref
Giuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, Guido Granata, Milo Gatti, Luigi Principe, Alessandro Russo, Andrea Gizzi, Rita Pallone, Antonio Cascio & Chiara Iaria. (2023) Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections. Antibiotics 12:12, pages 1653.
Crossref
Crossref
Tugba SARI, Şükran KÖSE, Hüseyin TURGUT, Müge ÖZGÜLER, Sinem AKKAYA IŞIK & Ayşe ÖZKAN ACAR. (2023) Clinical Value Of Intravenous Fosfomycin Combinationsİntravenöz Fosfomisin Kombinasyonlarının Klinik Değeri. İzmir Tıp Fakültesi Dergisi.
Crossref
Crossref
Martin Tuan Tran. (2023) New ways of using old antibiotics in pediatrics: Focus on fosfomycin. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43:7, pages 705-712.
Crossref
Crossref
Hidetada Hirakawa, Ayako Takita, Yumika Sato, Suguru Hiramoto, Yusuke Hashimoto, Noriyasu Ohshima, Yoji A. Minamishima, Masami Murakami & Haruyoshi Tomita. (2023)
Inactivation of
ackA
and
pta
Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in
Escherichia coli
. Microbiology Spectrum 11:3.
Crossref
Crossref
Antonio Anastasia, Silvia Bonura, Raffaella Rubino, Giovanni Maurizio Giammanco, Irene Miccichè, Maria Rita Di Pace, Claudia Colomba & Antonio Cascio. (2023) The Use of Intravenous Fosfomycin in Clinical Practice: A 5-Year Retrospective Study in a Tertiary Hospital in Italy. Antibiotics 12:6, pages 971.
Crossref
Crossref
Bisma Jan, Rafia Jan, Suhaib Afzal, Mehrose Ayoub & Mubashir Hussain Masoodi. 2023. Non-traditional Approaches to Combat Antimicrobial Drug Resistance. Non-traditional Approaches to Combat Antimicrobial Drug Resistance
79
100
.
Matthaios Papadimitriou-Olivgeris, Damien Jacot & Benoit Guery. 2022. Pseudomonas aeruginosa. Pseudomonas aeruginosa
425
445
.
Maggie Wong, Davie Wong & Sangita Malhotra. (2021)
Intravenous fosfomycin as salvage therapy for osteomyelitis caused by multidrug-resistant
Pseudomonas aeruginosa
. American Journal of Health-System Pharmacy 78:24, pages 2209-2215.
Crossref
Crossref
Corneliu Ovidiu Vrancianu, Elena Georgiana Dobre, Irina Gheorghe, Ilda Barbu, Roxana Elena Cristian & Mariana Carmen Chifiriuc. (2021) Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections. Microorganisms 9:4, pages 730.
Crossref
Crossref
Saleh Alammari, Abdullah AlRuwaili, Abdulaziz Almutairi & Adeeb Alshammari. (2021) Treatment of resistant urinary tract infection: a systematic review. International Journal of Medicine in Developing Countries, pages 968-973.
Crossref
Crossref
Shanti Narayanasamy, Roger L Nation, Andrew A Mahony, M Lindsay Grayson, Jason C Kwong, Norelle L Sherry, Sharmila Khumra, Andrew G Ellis, Albert G Frauman & Natasha E Holmes. (2021)
Cure of Limb-Threatening XDR
Pseudomonas aeruginosa
Infection: Combining Genome Sequencing, Therapeutic Drug Level Monitoring, and Surgical Debridement
. Open Forum Infectious Diseases 8:1.
Crossref
Crossref
Yi-Chien Lee, Pao-Yu Chen, Jann-Tay Wang & Shan-Chwen Chang. (2020) Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
Sean AinsworthSean Ainsworth. 2020. Neonatal Formulary. Neonatal Formulary
308
348
.
Matteo Bassetti, Elena Graziano, Marco Berruti & Daniele Roberto Giacobbe. (2019) The role of fosfomycin for multidrug-resistant gram-negative infections. Current Opinion in Infectious Diseases 32:6, pages 617-625.
Crossref
Crossref
Trang D. Trinh, Jordan R. Smith & Michael J. Rybak. (2019) Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the Epoxide. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:11, pages 1077-1094.
Crossref
Crossref
C. Putensen, B. Ellger, S. G. Sakka, A. Weyland, K. Schmidt, M. Zoller, N. Weiler, D. Kindgen-Milles, U. Jaschinski, J. Weile, S. Lindau, M. Kieninger, A. Faltlhauser, N. Jung, P. Teschendorf, M. Adamzik, M. Gründling, T. Wahlers, H. Gerlach & F.-A. Litty. (2019) Current clinical use of intravenous fosfomycin in ICU patients in two European countries. Infection 47:5, pages 827-836.
Crossref
Crossref
Ilias Karaiskos, Styliani Lagou, Konstantinos Pontikis, Vasiliki Rapti & Garyphallia Poulakou. (2019) The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Frontiers in Public Health 7.
Crossref
Crossref
Christopher J. Royer & Paul D. Cook. (2019)
A structural and functional analysis of the glycosyltransferase BshA from
Staphylococcus aureus
: Insights into the reaction mechanism and regulation of bacillithiol production
. Protein Science 28:6, pages 1083-1094.
Crossref
Crossref
Balaji Veeraraghavan, Agila Kumari Pragasam, Yamuna Devi Bakthavatchalam, Shalini Anandan, Subramanian Swaminathan & Balasubramanian Sundaram. (2019) Colistin-Sparing Approaches with Newer Antimicrobials to Treat Carbapenem-Resistant Organisms: Current Evidence and Future Prospects. Indian Journal of Medical Microbiology 37:1, pages 72-90.
Crossref
Crossref
Mina Aghamali, Mansour Sedighi, Abed Zahedi bialvaei, Nima Mohammadzadeh, Sara Abbasian, Zahra Ghafouri & Ebrahim Kouhsari. (2019) Fosfomycin: mechanisms and the increasing prevalence of resistance. Journal of Medical Microbiology 68:1, pages 11-25.
Crossref
Crossref
Lauro Vieira Perdigão Neto, Maura S Oliveira, Roberta Cristina Ruedas Martins, Ana Paula Marchi, Juliana Januário Gaudereto, Lucianna Auxi Teixeira Josino da Costa, Lia Fernandes Alves de Lima, Christianne Fernandes Valente Takeda, Silvia F Costa & Anna S Levin. (2019) Fosfomycin in severe infections due to genetically distinct pan-drug-resistant Gram-negative microorganisms: synergy with meropenem. Journal of Antimicrobial Chemotherapy 74:1, pages 177-181.
Crossref
Crossref
George G. Zhanel, Michael A. Zhanel & James A. Karlowsky. (2018) Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology 2018, pages 1-13.
Crossref
Crossref
Natalia V. Ortiz Zacarías, Anneke C. Dijkmans, Jacobus Burggraaf, Johan W. Mouton, Erik B. Wilms, Cees van Nieuwkoop, Daan J. Touw, Ingrid M. C. Kamerling & Jasper Stevens. (2018) Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens. Pharmacology Research & Perspectives 6:1, pages e00378.
Crossref
Crossref
Anneke Corinne Dijkmans, Natalia Veneranda Ortiz Zacarías, Jacobus Burggraaf, Johan Willem Mouton, Erik Wilms, Cees van Nieuwkoop, Daniel Johannes Touw, Jasper Stevens & Ingrid Maria Catharina Kamerling. (2017) Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics 6:4, pages 24.
Crossref
Crossref
B. Grabein, W. Graninger, J. Rodríguez Baño, A. Dinh & D.B. Liesenfeld. (2017) Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature. Clinical Microbiology and Infection 23:6, pages 363-372.
Crossref
Crossref
Tiffany R. Keepers, Marcela Gomez, Chris Celeri, Kevin M. Krause, Donald Biek & Ian Critchley. (2017) Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012. Infectious Diseases and Therapy 6:2, pages 233-243.
Crossref
Crossref
Piseth Seng, Sophie Amrane, Matthieu Million & Andreas Stein. (2017) Old antimicrobials and Gram-positive cocci through the example of infective endocarditis and bone and joint infections. International Journal of Antimicrobial Agents 49:5, pages 558-564.
Crossref
Crossref
Keith S. Kaye, Ana C. Gales & Grégory Dubourg. (2017) Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes. International Journal of Antimicrobial Agents 49:5, pages 542-548.
Crossref
Crossref
Kumiko Kurabayashi, Koichi Tanimoto, Haruyoshi Tomita & Hidetada Hirakawa. (2017) Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic Escherichia coli (EHEC) by Elevating the Expression of glpT and uhpT under Anaerobic Conditions. Frontiers in Microbiology 8.
Crossref
Crossref
Tulin Demir & Tuncay Buyukguclu. (2017) Fosfomycin: In vitro efficacy against multidrug-resistant isolates beyond urinary isolates. Journal of Global Antimicrobial Resistance 8, pages 164-168.
Crossref
Crossref
Kelsey R. Winchell, Paul W. Egeler, Andrew J. VanDuinen, Luke B. Jackson, Mary E. Karpen & Paul D. Cook. (2016) A Structural, Functional, and Computational Analysis of BshA, the First Enzyme in the Bacillithiol Biosynthesis Pathway. Biochemistry 55:33, pages 4654-4665.
Crossref
Crossref
Matthew E. Falagas, Evridiki K. Vouloumanou, George Samonis & Konstantinos Z. Vardakas. (2016) Fosfomycin. Clinical Microbiology Reviews 29:2, pages 321-347.
Crossref
Crossref
Suzanne L. Parker, Jeffrey Lipman, George Dimopoulos, Jason A. Roberts & Steven C. Wallis. (2015) A validated method for the quantification of fosfomycin on dried plasma spots by HPLC–MS/MS: Application to a pilot pharmacokinetic study in humans. Journal of Pharmaceutical and Biomedical Analysis 115, pages 509-514.
Crossref
Crossref
Kumiko Kurabayashi, Koichi Tanimoto, Shinobu Fueki, Haruyoshi Tomita & Hidetada Hirakawa. (2015) Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions. Antimicrobial Agents and Chemotherapy 59:10, pages 6352-6360.
Crossref
Crossref
Matthew E. Falagas & Petros I. Rafailidis. (2015)
Editorial Commentary:
Fosfomycin: The Current Status of the Drug
. Clinical Infectious Diseases 61:7, pages 1144-1146.
Crossref
Crossref
Kumiko Kurabayashi, Yuko Hirakawa, Koichi Tanimoto, Haruyoshi Tomita & Hidetada Hirakawa. (2015) Identification of a Second Two-Component Signal Transduction System That Controls Fosfomycin Tolerance and Glycerol-3-Phosphate Uptake. Journal of Bacteriology 197:5, pages 861-871.
Crossref
Crossref
R Garg, V Gupta, J Chander & M Kaur. (2015) Report of carbapenem resistant Ps. aeruginosa, isolates carrying ESBLs, AmpC and MBL enzymes based on phenotypic methodology and susceptibility to Fosfomycin. Indian Journal of Medical Microbiology 33, pages S160-S161.
Crossref
Crossref
Suzanne L. Parker, Jeffrey Lipman, Jason A. Roberts & Steven C. Wallis. (2015) A simple LC–MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: Application to a pilot pharmacokinetic study in humans. Journal of Pharmaceutical and Biomedical Analysis 105, pages 39-45.
Crossref
Crossref
Nadim Cassir, Jean-Marc Rolain & Philippe Brouqui. (2014) A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Frontiers in Microbiology 5.
Crossref
Crossref
Julia L. Reffert & Winter J. Smith. (2014) Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial Infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:8, pages 845-857.
Crossref
Crossref
Yun-Jian Wu, Qing-Chuan Zheng, Ji-Long Zhang, Wen-Ting Chu, Ying-Lu Cui, Yan Wang & Hong-Xing Zhang. (2014) Fosfomycin Induced Structural Change in Fosfomycin Resistance Kinases FomA: Molecular Dynamics and Molecular Docking Studies. Journal of Molecular Modeling 20:5.
Crossref
Crossref
K. Kurabayashi, Y. Hirakawa, K. Tanimoto, H. Tomita & H. Hirakawa. (2013) Role of the CpxAR Two-Component Signal Transduction System in Control of Fosfomycin Resistance and Carbon Substrate Uptake. Journal of Bacteriology 196:2, pages 248-256.
Crossref
Crossref
Chang-Seop LeeYohei Doi. (2014) Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens. Infection & Chemotherapy 46:3, pages 149.
Crossref
Crossref
Konstantinos Pontikis, Ilias Karaiskos, Styliani Bastani, George Dimopoulos, Michalis Kalogirou, Maria Katsiari, Angelos Oikonomou, Garyphallia Poulakou, Emmanuel Roilides & Helen Giamarellou. (2014) Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. International Journal of Antimicrobial Agents 43:1, pages 52-59.
Crossref
Crossref
María Díez-Aguilar, María-Isabel Morosini, Rosa del Campo, María García-Castillo, Javier Zamora & Rafael Cantón. (2013)
In Vitro
Activity of Fosfomycin against a Collection of Clinical Pseudomonas aeruginosa Isolates from 16 Spanish Hospitals: Establishing the Validity of Standard Broth Microdilution as Susceptibility Testing Method
. Antimicrobial Agents and Chemotherapy 57:11, pages 5701-5703.
Crossref
Crossref
Suzanne Parker, Jeffrey Lipman, Despoina Koulenti, George Dimopoulos & Jason A. Roberts. (2013) What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review. International Journal of Antimicrobial Agents 42:4, pages 289-293.
Crossref
Crossref
Ö. Azap, T. Togan, A. Yesilkaya, H. Arslan & M. Haberal. (2013) Antimicrobial Susceptibilities of Uropathogen Escherichia coli in Renal Transplant Recipients: Dramatic Increase in Ciprofloxacin Resistance. Transplantation Proceedings 45:3, pages 956-957.
Crossref
Crossref
David van Duin, Keith S. Kaye, Elizabeth A. Neuner & Robert A. Bonomo. (2013) Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagnostic Microbiology and Infectious Disease 75:2, pages 115-120.
Crossref
Crossref
P. D. Croughs, B. Li, J. A. A. Hoogkamp-Korstanje & E. Stobberingh. (2012) Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands. European Journal of Clinical Microbiology & Infectious Diseases 32:2, pages 283-288.
Crossref
Crossref